中国儿童睫状肌麻痹验光及安全用药专家共识(2019年)

2019-03-30 中国眼科相关专家组(统称) 中华眼科杂志.2019,55(1):7-12.

睫状肌麻痹下视网膜检影验光是儿童屈光不正检查的主要环节,而睫状肌麻痹剂的选择和应用对于儿童验光的准确性和用药安全性均至关重要。长期以来阿托品一直是我国儿童最常用的睫状肌麻痹剂。近几十年来合成的抗胆碱药物托品酰胺、环喷托酯陆续在国外临床使用,尤其环喷托酯目前在西方国家已成为大多数儿童睫状肌麻痹验光的首选药物。在我国,眼科医师对儿童验光应如何合理选择睫状肌麻痹剂尚存在争议。为了规范睫状肌麻痹剂在我国儿

中文标题:

中国儿童睫状肌麻痹验光及安全用药专家共识(2019年)

发布日期:

2019-03-30

简要介绍:

睫状肌麻痹下视网膜检影验光是儿童屈光不正检查的主要环节,而睫状肌麻痹剂的选择和应用对于儿童验光的准确性和用药安全性均至关重要。长期以来阿托品一直是我国儿童最常用的睫状肌麻痹剂。近几十年来合成的抗胆碱药物托品酰胺、环喷托酯陆续在国外临床使用,尤其环喷托酯目前在西方国家已成为大多数儿童睫状肌麻痹验光的首选药物。在我国,眼科医师对儿童验光应如何合理选择睫状肌麻痹剂尚存在争议。为了规范睫状肌麻痹剂在我国儿童屈光检查中的应用,保证儿童睫状肌麻痹验光结果的可靠性和用药的安全性,也为患者就诊提供方便,中华医学会眼科学分会斜视与小儿眼科学组组织我国相关领域专家,以国内外循证医学研究成果为基础,参考本专业领域专家的临床经验,并结合我国目前临床可使用的睫状肌麻痹成品制剂的特点,讨论并制定了专家共识,旨在指导我国眼科医师在临床工作中合理选择使用睫状肌麻痹剂,使我国儿童眼病诊疗工作更加规范化和人性化。 

拓展指南:斜视相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国儿童睫状肌麻痹验光及安全用药专家共识(2019年))] GetToolGuiderByIdResponse(projectId=1, id=8f8241c001e190b6, title=中国儿童睫状肌麻痹验光及安全用药专家共识(2019年), enTitle=, guiderFrom=中华眼科杂志.2019,55(1):7-12., authorId=null, author=, summary=睫状肌麻痹下视网膜检影验光是儿童屈光不正检查的主要环节,而睫状肌麻痹剂的选择和应用对于儿童验光的准确性和用药安全性均至关重要。长期以来阿托品一直是我国儿童最常用的睫状肌麻痹剂。近几十年来合成的抗胆碱药物托品酰胺、环喷托酯陆续在国外临床使用,尤其环喷托酯目前在西方国家已成为大多数儿童睫状肌麻痹验光的首选药物。在我国,眼科医师对儿童验光应如何合理选择睫状肌麻痹剂尚存在争议。为了规范睫状肌麻痹剂在我国儿, cover=, journalId=null, articlesId=null, associationId=1043, associationName=中国眼科相关专家组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Sat Mar 30 23:37:30 CST 2019, originalUrl=, linkOutUrl=, content=<div>睫状肌麻痹下视网膜检影验光是儿童屈光不正检查的主要环节,而睫状肌麻痹剂的选择和应用对于儿童验光的准确性和用药安全性均至关重要。长期以来阿托品一直是我国儿童最常用的睫状肌麻痹剂。近几十年来合成的抗胆碱药物托品酰胺、环喷托酯陆续在国外临床使用,尤其环喷托酯目前在西方国家已成为大多数儿童睫状肌麻痹验光的首选药物。在我国,眼科医师对儿童验光应如何合理选择睫状肌麻痹剂尚存在争议。为了规范睫状肌麻痹剂在我国儿童屈光检查中的应用,保证儿童睫状肌麻痹验光结果的可靠性和用药的安全性,也为患者就诊提供方便,中华医学会眼科学分会斜视与小儿眼科学组组织我国相关领域专家,以国内外循证医学研究成果为基础,参考本专业领域专家的临床经验,并结合我国目前临床可使用的睫状肌麻痹成品制剂的特点,讨论并制定了专家共识,旨在指导我国眼科医师在临床工作中合理选择使用睫状肌麻痹剂,使我国儿童眼病诊疗工作更加规范化和人性化。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>斜视</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=56aa21c001601563" title="斜视诊治指南" target=_blank>斜视诊治指南</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=294891c0009310ca" title="2012 AAO 内斜视和外斜视 (PPP)" target=_blank>2012 AAO 内斜视和外斜视 (PPP)</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E6%96%9C%E8%A7%86" target=_blank>有关斜视更多指南</a></ul>, tagList=[TagDto(tagId=88263, tagName=儿童睫状肌麻痹), TagDto(tagId=59368, tagName=验光), TagDto(tagId=37405, tagName=安全用药)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7518, appHits=289, showAppHits=5, pcHits=4601, showPcHits=3951, likes=90, shares=15, comments=7, approvalStatus=1, publishedTime=Sat Mar 30 23:37:30 CST 2019, publishedTimeString=2019-03-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 30 23:37:30 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:22:44 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国儿童睫状肌麻痹验光及安全用药专家共识(2019年))])
中国儿童睫状肌麻痹验光及安全用药专家共识(2019年)
下载请点击:
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=919242, encodeId=270e9192424f, content=谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/22/f7afb35f5678b42c5f6ba7719ce0509a.jpg, createdBy=0e532081557, createdName=杰瑞006, createdTime=Sat Jan 23 17:55:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917790, encodeId=403491e79034, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e56b5453857, createdName=ms2000000474051546, createdTime=Mon Jan 18 18:10:30 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882306, encodeId=2acf88230621, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:19 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882305, encodeId=f68488230565, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:14 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882304, encodeId=369e88230496, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:11 CST 2020, time=2020-09-03, status=1, ipAttribution=)]
    2021-01-23 杰瑞006

    谢谢分享!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=919242, encodeId=270e9192424f, content=谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/22/f7afb35f5678b42c5f6ba7719ce0509a.jpg, createdBy=0e532081557, createdName=杰瑞006, createdTime=Sat Jan 23 17:55:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917790, encodeId=403491e79034, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e56b5453857, createdName=ms2000000474051546, createdTime=Mon Jan 18 18:10:30 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882306, encodeId=2acf88230621, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:19 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882305, encodeId=f68488230565, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:14 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882304, encodeId=369e88230496, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:11 CST 2020, time=2020-09-03, status=1, ipAttribution=)]
    2021-01-18 ms2000000474051546

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=919242, encodeId=270e9192424f, content=谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/22/f7afb35f5678b42c5f6ba7719ce0509a.jpg, createdBy=0e532081557, createdName=杰瑞006, createdTime=Sat Jan 23 17:55:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917790, encodeId=403491e79034, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e56b5453857, createdName=ms2000000474051546, createdTime=Mon Jan 18 18:10:30 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882306, encodeId=2acf88230621, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:19 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882305, encodeId=f68488230565, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:14 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882304, encodeId=369e88230496, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:11 CST 2020, time=2020-09-03, status=1, ipAttribution=)]
    2020-09-03 14643f34m67暂无昵称

    学习好资料!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=919242, encodeId=270e9192424f, content=谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/22/f7afb35f5678b42c5f6ba7719ce0509a.jpg, createdBy=0e532081557, createdName=杰瑞006, createdTime=Sat Jan 23 17:55:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917790, encodeId=403491e79034, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e56b5453857, createdName=ms2000000474051546, createdTime=Mon Jan 18 18:10:30 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882306, encodeId=2acf88230621, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:19 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882305, encodeId=f68488230565, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:14 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882304, encodeId=369e88230496, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:11 CST 2020, time=2020-09-03, status=1, ipAttribution=)]
    2020-09-03 14643f34m67暂无昵称

    学习好资料!!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=919242, encodeId=270e9192424f, content=谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/22/f7afb35f5678b42c5f6ba7719ce0509a.jpg, createdBy=0e532081557, createdName=杰瑞006, createdTime=Sat Jan 23 17:55:04 CST 2021, time=2021-01-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=917790, encodeId=403491e79034, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e56b5453857, createdName=ms2000000474051546, createdTime=Mon Jan 18 18:10:30 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882306, encodeId=2acf88230621, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:19 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882305, encodeId=f68488230565, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:14 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882304, encodeId=369e88230496, content=学习好资料!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c4bd5125128, createdName=14643f34m67暂无昵称, createdTime=Thu Sep 03 01:08:11 CST 2020, time=2020-09-03, status=1, ipAttribution=)]
    2020-09-03 14643f34m67暂无昵称

    学习好资料!!

    0